期刊文献+

远端保护装置在急性心肌梗死急诊经皮冠状动脉介入治疗中的应用

Application of distal protective device during emergent percutaneous coronary intervention in acute myocardial infarction patients
下载PDF
导出
摘要 急诊经皮冠状动脉介入治疗是目前治疗急性心肌梗死的首选方法。在大部分急性心肌梗死的患者中,急诊冠脉造影均显示存在较重的血栓负荷,而对富含血栓的冠状动脉行介入操作必然会增加远端栓塞的可能性。约13%~80.9%的病人术后出现慢血流或无再流现象,远端微循环栓塞系造成无再流现象最重要的原因之一。近年来问世的各种远端保护装置为防治远端栓塞提供了一种有效的方法。 Percutaneous coronary intervention (PCI) is of choice in the treatment of acute myocardial infarction (AMI). Emergent angiogram showed lots of thrombi in the coronary of most AMI patients, so emergent PCI may increase the possibility of distal embolization in these patients, slow-flow or no-reflow phenomenon in 13%-80.9% of the patients, and distal embolization is one of the main reasons for no-reflow phenomenon. In reeent years, several distal protective devices have been invented and provided effective ways for the prevention of distal embolization.
出处 《兰州大学学报(医学版)》 CAS 2007年第1期89-92,共4页 Journal of Lanzhou University(Medical Sciences)
关键词 经皮冠状动脉介入治疗 急性心肌梗死 无再流 远端保护装置 percutaneous coronary intervention acute myocardial infarction no-reflow distal protective device
  • 相关文献

参考文献13

  • 1[1]FSUTER V,BADIMON L,BADIMON J,et al.The pathogenesis of coronary artery disease and the acute coronary syndromes[J].N Engl Med,1992,326:242-250.
  • 2[2]MORISHIMA I,SONE T,OKUMURA K,et al.Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction[J].Journal of the American College Cardiology,2000,36:1202-1209.
  • 3[3]IWAKURA K,ITO H,NISHIKAWA N,et al.Early temporal changes in coronary flow velocity patterns in patients with acute myocardial infarction demonstrating the "no-reflow" phenomenon[J].Am J Cardiol,1999,84:415-419.
  • 4[4]YAMADA D M,TOPOL E J.Microvascular embolization in acute coronary syndromes[J].Acut Cor Syn,2001,4:1-17.
  • 5[5]MICHAELS A D,GIBSON C M,BARRON H W.Microvascular dysfunction in acute myocardial infarction:focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon[J].Am J Cardiol,2000,85:50-60.
  • 6[6]THERON J G,PAYELLE G G,COSKUN O,et al.Carotid artery stenosis:treatment with protected balloon angioplasty and stent placement[J].Radiology,1996,201:627-636.
  • 7[7]WALTERS D L,HARDING S A,PALACIOS I F,et al.The use of mechanical devices as adjuncts to intracoronary stenting[J].Curr Opin Cardiol,2001,16:300-305.
  • 8[8]TOPOL E J,YADAV J S.Recognition of the importance of embolization in atherosclerotic vascular disease[J].Circulation,2000,101:570-580.
  • 9[9]KALARIA V G,ROUCH C,BOURDILLON P D,et al.Distal emboliprotection in patients undergoing percutaneous coronary intervenaffter a recent myocardial infarction[J].Cathet Cardiovasc Intervent,2002,57:54-60.
  • 10[10]HOF A M J,LIEM A,SURYAPRANATA H,et al.Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction:myocardial brush grade[J].Circulation,1998,97:2302-2306.

二级参考文献18

  • 1Morishima 1, Sone T, Okumura K, et al, Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. JACC, 2000,36:1202-1209.
  • 2Tanaka A, Kawarabayashi T, Nishibori Y, et al, No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation, 2002, 105:2148-2152.
  • 3vHof AM J, Liem A, Suryapranata H, et al, Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial brush grade. Circulation,1998,97 : 2302-2306.
  • 4Iwakura K, Ito H, Nishikawa N, et al, Early temporal changes in coronary flow velocity patterns in patients with acute myocardial infarction demonstrating the “no-reflow” phenomenon. Am J Cardiol,1999,84:415-419.
  • 5Yamada DM, Topol EJ. Microvascular embolization in acute coronary syndromes. Acut Cor Syn, 2001,4:1-17.
  • 6Rezkalla SH, Kloner RA, No-reflow phenomenon. Circulation, 2002,105 : 656-662.
  • 7Michaels AD, Gibson CM, Barton HW. Microvascnlar dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol,2000,85:50B-60B.
  • 8Bain DS, Wahr D, George B, et al, Randomized trial of a distal embolic protection device during percutaneous interven of saphenous vein aorto-coronary bypass grafts. Circulalion, 2002,105:r13-r18.
  • 9U.S. SAPPHIRE Study Group. Preliminary results of carotid stenting with ANGIOGUARD XP emboli protection guidewire vs. surgery for carotid artery blockages in high risk patients. AHA, 2002,11, chicago,IL.
  • 10Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction [J]. JACC, 2000;36(4):1202-1209.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部